% Expired Patents = 12.5

Forward Citations = 20

Loading Chart...

6 inventors (with patents filed for the assignee):

Henry B Abajian (8 out of 8 patents)

Joseph J Hlavka (7 out of 53 patents)

John Fowler Noble (6 out of 6 patents)

4. Matthew R Pincus (3 out of 16 patents)

5. Andrew S Kende (3 out of 25 patents)

6. John P Feighner (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 6767897 - Therapeutic uses of tri-, tetra-, penta-, and polypeptides (2004-07-27),

2. 6093797 - Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an (2000-07-25),

3. 5990172 - Peptidomimetics for the treatment of HIV infection (1999-11-23),

4. 5910478 - Peptidomimetics inhibiting the oncogenic action of p21 ras (1999-06-08),

5. 5840683 - Peptides inhibiting the oncogenic action of p21 ras (1998-11-24),

6. 5767083 - Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an (1998-06-16),

7. 5721207 - Method for treatment of pain (1998-02-24),

8. 5589460 - Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an (1996-12-31),

Company Overview

Innapharma, Inc. is a leading pharmaceutical company specializing in the development and production of innovative drugs and medical solutions. With a focus on improving patient outcomes and addressing unmet medical needs, Innapharma is committed to pushing the boundaries of healthcare through research and innovation. Our team of dedicated experts work tirelessly to bring cutting-edge treatments to market, ensuring the highest quality and efficacy for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#2 in Park Ridge, NJ

#1,343 in New Jersey

#35,893 in US

Park Ridge, NJ, United States of America

Innapharma, Inc.

Forward Citations = 20

6 inventors:

Henry B Abajian (8 out of 8 patents)

Joseph J Hlavka (7 out of 53 patents)

John Fowler Noble (6 out of 6 patents)

4. Matthew R Pincus (3 out of 16 patents)

5. Andrew S Kende (3 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Innapharma, Inc.. Retrieved from https://idiyas.com/company/innapharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]